Food News and Research

RSS

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

Study finds pre-packaged set meals can help weight loss more than self-directed dieting

A study conducted by an obesity and food research centre in Hull has found that a provision of pre-packaged set meals can help people lose more weight compared to self-directed dieting.

10 Jan 2014

Viewpoints: Don't blame insurers for health system problems; Obama's 'management failure;' Texas abortion case heads to court

[The] problem with the Affordable Care Act isn't the insurance industry. In fact, the main benefits of nationalized health care can be achieved in systems with hundreds, even thousands, of for-profit insurers. ...

10 Jan 2014

PaxVax reports interim data from Phase 3 cholera challenge study of PXVX0200

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced interim data from a Phase 3 cholera challenge study of its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Trial investigators compared the rate of diarrhea in participants vaccinated with PXVX0200 to the rate in participants who had received placebo.

10 Jan 2014

CalNaturale Svelte helps individuals looking to achieve new health goals in 2014

To ring in the New Year and help make health and fitness resolutions stick through the winter and beyond, CalNaturale Svelte®, the premium line of USDA Certified organic protein shakes that provides great taste, sustained nutrition and energy through pure and simple ingredients, is offering simple ways for people to stay "Svelte" this season.

10 Jan 2014

Nottingham scientists use MRI technology to assist in treatment, diagnosis of irritable bowel syndrome

Scientists at The University of Nottingham are leading the world in exploiting MRI technology to assist in the treatment and diagnosis of Irritable Bowel Syndrome (IBS), a condition that causes serious inconvenience and discomfort to sufferers.

10 Jan 2014

SHY hypothesis challenges theory that sleep strengthens brain connections

Why do animals ranging from fruit flies to humans all need to sleep? After all, sleep disconnects them from their environment, puts them at risk and keeps them from seeking food or mates for large parts of the day.

10 Jan 2014

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.

10 Jan 2014

Researchers examine genetic variants associated with increased risk of type 2 diabetes

Contrary to a common belief, researchers have shown that genetic regions associated with increased risk of type 2 diabetes were unlikely to have been beneficial to people at stages through human evolution.

10 Jan 2014

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.

10 Jan 2014

TSRI researchers develop new fluid biopsy technique to identify patients at high risk of heart attack

A new "fluid biopsy" technique that could identify patients at high risk of a heart attack by identifying specific cells as markers in the bloodstream has been developed by a group of researchers at The Scripps Research Institute.

9 Jan 2014

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

9 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.

9 Jan 2014

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

Scientists at The University of Nottingham are leading the world in exploiting MRI technology to assist in the treatment and diagnosis of Irritable Bowel Syndrome, a condition that causes serious inconvenience and discomfort to sufferers.

9 Jan 2014

K2M receives FDA clearance to market CAYMAN Minimally Invasive plate system

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company’s CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.

9 Jan 2014

Full-service restaurant chains serve foods high in calories, fat

Food prepared away from home is typically higher in calories and lower in nutrition than food prepared at home, but it now makes up more than one-third of all calories purchased in the United States. Consumers tend to view full-service restaurants as providing healthier, higher quality food than fast-food restaurants, but some studies have found much higher calorie, fat, and sodium levels in food at full-service restaurants.

9 Jan 2014

UCSB psychology professor finds that weight-stigmatizing messages may have the opposite effect

If you're one of the millions of people who count losing weight among their top New Year's resolutions, you might want to pay careful attention to some new findings by UC Santa Barbara psychology professor Brenda Major.

9 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Study links dietary fat content with excess of abdominal fat in adolescents, irrespective of physical exercise

The prevalence of excess weight and obesity among adolescents and, as a result, the concomitant problems, has increased considerably in recent years. A study by the UPV/EHU has confirmed that, irrespective of the total calories consumed and the physical activity done, an excessive proportion of fat in the diet leads to a greater accumulation of fat in the abdomen.

9 Jan 2014

Food News and Research

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

Study finds pre-packaged set meals can help weight loss more than self-directed dieting

Viewpoints: Don't blame insurers for health system problems; Obama's 'management failure;' Texas abortion case heads to court

PaxVax reports interim data from Phase 3 cholera challenge study of PXVX0200

CalNaturale Svelte helps individuals looking to achieve new health goals in 2014

Nottingham scientists use MRI technology to assist in treatment, diagnosis of irritable bowel syndrome

SHY hypothesis challenges theory that sleep strengthens brain connections

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

Researchers examine genetic variants associated with increased risk of type 2 diabetes

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

TSRI researchers develop new fluid biopsy technique to identify patients at high risk of heart attack

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

K2M receives FDA clearance to market CAYMAN Minimally Invasive plate system

Full-service restaurant chains serve foods high in calories, fat

UCSB psychology professor finds that weight-stigmatizing messages may have the opposite effect

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Study links dietary fat content with excess of abdominal fat in adolescents, irrespective of physical exercise

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News